| Tixagevimab/cilgavimab pre‐exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave A Al Jurdi, L Morena, M Cote, E Bethea, J Azzi, LV Riella American Journal of Transplantation 22 (12), 3130-3136, 2022 | 125 | 2022 |
| Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients A Al Jurdi, RB Gassen, TJ Borges, IT Lape, L Morena, O Efe, Z Solhjou, ... Kidney International 101 (6), 1282-1286, 2022 | 47 | 2022 |
| An EBV+ lymphoepithelioma-like cholangiocarcinoma in a young woman with chronic hepatitis B SV Gearty, A Al Jurdi, ME Pittman, R Gupta BMJ Case Reports CP 12 (7), e229520, 2019 | 22 | 2019 |
| Epilepsy in Qatar: causes, treatment, and outcome N Haddad, G Melikyan, H Al Hail, A Al Jurdi, F Aqeel, A Elzafarany, ... Epilepsy & Behavior 63, 98-102, 2016 | 22 | 2016 |
| Non-invasive monitoring for rejection in kidney transplant recipients after SARS-CoV-2 mRNA vaccination A Al Jurdi, RB Gassen, TJ Borges, Z Solhjou, FE Hullekes, IT Lape, O Efe, ... Frontiers in Immunology 13, 838985, 2022 | 19 | 2022 |
| Monkeypox in transplant recipients: no breaks between outbreaks A Al Jurdi, CN Kotton Transplantation 106 (11), e512-e513, 2022 | 17 | 2022 |
| Antibody-mediated rejection: prevention, monitoring and treatment dilemmas S Rodriguez-Ramirez, A Al Jurdi, A Konvalinka, LV Riella Current opinion in organ transplantation 27 (5), 405-414, 2022 | 13 | 2022 |
| T cell depletion increases humoral response by favoring T follicular helper cells expansion RB Gassen, TJ Borges, MJ Pérez-Sáez, H Zhang, A Al Jurdi, ... American Journal of Transplantation 22 (7), 1766-1778, 2022 | 8 | 2022 |
| Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients AA Jurdi, RB Gassen, TJ Borges, IT Lape, L Morena, O Efe, Z Solhjou, ... MedRxiv, 2022.01. 03.22268649, 2022 | 6 | 2022 |
| Immune checkpoint inhibitors in kidney transplantation N Alzahrani, A Al Jurdi, LV Riella Current Opinion in Organ Transplantation 28 (1), 46-54, 2023 | 4 | 2023 |
| Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole J Huggins, A Al Jurdi, R Gupta Medical mycology case reports 23, 34-36, 2019 | 4 | 2019 |
| Factors associated with reduced anti-SARS-CoV-2 antibody responses after mRNA vaccination in kidney transplant recipients on belatacept L Morena, A Al Jurdi, J Azzi, J Fishman, LV Riella Kidney International Reports 7 (11), 2513-2516, 2022 | 3 | 2022 |
| A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models O Efe, RB Gassen, L Morena, Y Ganchiku, A Al Jurdi, IT Lape, ... The Journal of Clinical Investigation 134 (5), 2024 | 2 | 2024 |
| Tixagevimab–cilgavimab Preexposure Prophylaxis in Solid Organ Transplant Recipients Is Associated With Fewer Breakthrough SARS-CoV-2 Infections, Except During the BA. 5 Period A Al Jurdi, L Morena, R Verhoeff, N Alzahrani, CN Kotton, LV Riella Transplantation 107 (9), e238-e240, 2023 | 2 | 2023 |
| Antibody responses against emerging SARS-CoV-2 Omicron lineages after the fourth dose of mRNA vaccine in kidney transplant recipients A Al Jurdi, RB Gassen, TJ Borges, IT Lape, L Morena, F Hullekes, O Efe, ... Transplantation 107 (6), e178-e181, 2023 | 2 | 2023 |
| Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for … A Al Jurdi, L Morena, LV Riella American Journal of Transplantation 23 (3), 451-452, 2023 | 1 | 2023 |
| Delaying Kidney Transplantation in Patients With Prostate Cancer: Is It Warranted? A Al Jurdi, H Gilligan, A Cohen-Bucay Kidney Medicine 3 (6), 893-895, 2021 | 1 | 2021 |
| Successful Treatment of Posttransplant Monoclonal Gammopathy-associated C3 Glomerulopathy With Plasma Cell Clone-directed Therapy A Al Jurdi, AC Bucay, LV Riella, AJ Yee, C Abdelmalek, V Klepeis, ... Transplantation Direct 10 (5), e1616, 2024 | | 2024 |
| A humanized IL-2 mutein expands Tregs and prolongs survival in models O Efe, RB Gassen, L Morena, Y Ganchiku, A Al Jurdi, IT Lape, ... JOURNAL OF CLINICAL INVESTIGATION 134 (5), 2024 | | 2024 |
| Expanding the Donor Pool: Using Kidney and Heart Allografts From Hepatitis B–positive Donors C El Mouhayyar, A Al Jurdi, H Gilligan Transplantation 108 (3), 603-604, 2024 | | 2024 |
Leonardo V. RiellaMedical Director of Kidney Transplantation, Massachusetts General Hospital, Harvard Medical SchoolVerified email at mgh.harvard.edu
